オプションチェーンは、Verrica Pharmaceuticalsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Verrica Pharmaceuticalsの市場センチメントを評価します。.

Verrica Pharmaceuticals (NASDAQ:VRCA) 株価情報, オプションチェーン

Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Verrica Pharmaceuticals Inc. - Common Stock

Verrica Pharmaceuticals Inc

Ohio's recreational cannabis market has experienced a remarkable rise since its official rollout in August 2024. 
In less than four months, the state has accumulated over $143 million in recreational sales, <a href="https://dam.assets.ohio.gov/image/upload/com.ohio.gov/DCC/DCC_Historical_Sales_Data.pdf">according</a> to the Ohio Department of Commerce Division of Cannabis Control (DCC). 
This rapid growth is powered by the high demand and economic potential of legal cannabis in the Buckeye State.
<h3 class="wp-block-heading">Strong Launch And Steady Demand</h3>
Following Ohio voters' <a href="https://www.benzinga.com/markets/cannabis/23/11/35664155/ohio-legalizes-cannabis-and-overwhelmingly-approves-abortion-rights">approval of Issue 2</a> in 2023, the cannabis market opened with high expectations, allowing adults 21 and over to purchase cannabis products at licensed shops.
Dispensaries across <a href="https://www.benzinga.com/topic/cannabis-ohio">Ohio</a> reported an immediate influx of new customers, with demand remaining strong in major cities like Columbus and Cleveland.
Initial sales data reflects this enthusiasm, with the first month (August) alone generating over $44 million in sales.
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="636" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05121933/Captura-de-pantalla-2024-11-05-a-las-14.19.28-1024x636.png" alt="" class="wp-image-630811" style="width:536px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05121933/Captura-de-pantalla-2024-11-05-a-las-14.19.28-1024x636.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05121933/Captura-de-pantalla-2024-11-05-a-las-14.19.28-300x186.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05121933/Captura-de-pantalla-2024-11-05-a-las-14.19.28-768x477.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05121933/Captura-de-pantalla-2024-11-05-a-las-14.19.28.png 1204w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The momentum continued as monthly sales figures climbed steadily. 
September 2024 recorded nearly $54.7 million, while October sales surged to $76.3 million. By November, cumulative sales reached $143 million, underscoring the market's exponential growth. Growth between October and November reached an astonishing 47%.
This steady increase is expected to contribute significantly to Ohio's tax revenue, supported by the state's 10% tax on recreational cannabis purchases.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-">Village Farms Is Only Cannabis Operator Selected To Represent Weed Industry At DEA Rescheduling Hearing</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a></li>
</ul>
<h3 class="wp-block-heading">Expansion Opportunities For Operators</h3>
The swift uptake in Ohio's recreational market has attracted <a href="https://www.benzinga.com/money/multi-state-operators">multi-state operators</a> (MSOs) looking to capitalize on the state's burgeoning cannabis sector.
These MSOs are scaling up to meet consumer demand and expand their footprint within the state. With robust monthly sales, Ohio's cannabis industry presents substantial opportunities for businesses and investors aiming to establish a presence in this growing market.
Since the launch of adult-use sales, Ohio dispensaries have sold over 16,000 pounds of cannabis plant material. In addition to recreational sales, Ohio's established medical cannabis program continues to perform steadily, with medical patients driving consistent demand. 
The average price for manufactured cannabis products, such as edibles and concentrates, reached $29.21 in the last week of October. With 124 dual-use dispensaries authorized to serve both recreational and medical consumers, Ohio's cannabis infrastructure is well-positioned to support <a href="https://www.benzinga.com/markets/cannabis/24/10/41279057/ohios-recreational-cannabis-soars-98-million-in-revenue-within-just-two-months">further market growth</a> and meet the needs of its expanding customer base.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/08/40189647/trulieve-touts-third-consecutive-quarter-of-revenue-growth-narrows-q2-net-loss-97-yoy-launches-c">Trulieve Touts Third Consecutive Quarter Of Revenue Growth, Narrows Q2 Net Loss 97% YoY, Launches Cannabis Sales In Ohio</a></li>
</ul>
Cover: <a href="https://pixabay.com/es/photos/cleveland-ohio-ciudad-urbano-1888370/">Cleveland</a> in Pixabay

Cannabis

News

Retail Sales

Markets

Ohio's Cannabis Market Surges, Reaching $143M In Just 4 Months

WIIM

ZCAR

Zoomcar Holding shares are trading higher after the company reported a major expansion of its customer support team.

Prediction markets like Polymarket and Kalshi have <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41635149/2024-election-odds-on-polymarket-kalshi-show-trump-will-win-why-they-might-be-wrong">surged in popularity</a> during the <a href="https://www.benzinga.com/topic/2024-election">2024 election cycle</a>. Here&#8217;s all you need to know about the betting markets on Election Day as the U.S. elects a new president, either Donald Trump or Kamala Harris.
A Preface: Bettors on Polymarket, Kalshi, and other websites can continue betting even after the polls close. This is different than, say, sports betting where bets are locked after the game starts.
The betting odds will constantly update as votes are counted—favorable partial results for Trump will shift the odds in his column positively, and vice versa. As the race nears being called, the odds will converge on the winner.
The U.S. election could be called on Election Day—or it could take several weeks if a close tally requires recounts. Bettors can bet on the race at any time until the outcome is resolved.
Polymarket Policy: Polymarket <a href="https://polymarket.com/event/presidential-election-winner-2024?tid=1730829736678">lays</a> out its procedure for determining the outcome of its presidential market.
&#8220;This Presidential market resolves when the Associated Press, Fox, and NBC all call the election for the same candidate. In the unlikely event that doesn't happen, the market will remain open until inauguration and resolve to whoever gets inaugurated,&#8221; the website reads.
Kalshi Policy: Kalshi&#8217;s market is <a href="https://kalshi.com/markets/pres/presidential-elections">resolved</a> when the candidate is inaugurated.
&#8220;This market resolves when a candidate (or another representative of their party) is inaugurated as President for the term beginning January 20, 2025,&#8221; its rules read. &#8220;You can cash out of your position at any point in time.&#8221;
Why it Matters: Election night may present challenges such as confusion and misinformation. Bettors are encouraged to familiarize themselves with market rules before placing bets.
Several <a href="https://www.benzinga.com/news/24/11/41698607/kamala-harris-ready-if-trump-decides-to-falsely-declare-victory-we-are-prepared-to-respond">corroborating sources indicate</a> that Trump will prematurely declare victory on election night before all votes are counted. The Trump campaign <a href="https://www.benzinga.com/news/20/11/18202190/trump-declares-victory-ahead-of-results-from-key-states">acted similarly in 2020</a> in its loss to Joe Biden. Bettors should understand that while early results could indicate the direction of the race, it will ultimately not be resolved until the requirements of Polymarket and Kalshi are met.
According to reports, Kamala Harris's campaign and Democratic Party officials anticipate a <a href="https://www.benzinga.com/news/24/11/41698607/kamala-harris-ready-if-trump-decides-to-falsely-declare-victory-we-are-prepared-to-respond">premature victory declaration</a> by Trump in the 2024 election and are reportedly preparing a swift response. The Trump campaign <a href="https://www.benzinga.com/news/20/11/18202190/trump-declares-victory-ahead-of-results-from-key-states">took a similar approach</a> in 2020 during its loss to Joe Biden.
Bettors should be aware that while early results may indicate the potential direction of the race, the final outcome will not be determined until the conditions set by Polymarket and Kalshi are fulfilled.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41748843/trump-holds-edge-in-betting-markets-on-election-day-while-experts-call-tight-race-for-harris">Trump Holds Edge In Betting Markets On Election Day, While Experts Call Tight Race For Harris</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Politics

How Late Can You Bet On The US Election Through Polymarket, Kalshi? Everything You Need To Know

Trading Ideas

Hawaiian Electric Shares Halted Pending News

U.S. stocks traded higher toward the end of trading, with the S&amp;P 500 gaining around 1% on Tuesday.
The Dow traded up 0.96% to 42,197.88 while the NASDAQ rose 1.26% to 18,408.47. The S&amp;P 500 also rose, gaining, 1.03% to 5,771.80.
Check This Out: <a href="https://www.benzinga.com/news/24/11/41741538/wall-streets-most-accurate-analysts-spotlight-on-3-financial-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Consumer discretionary shares surged by 1.8% on Tuesday.
In trading on Tuesday, energy shares rose by just 0.3%.
Top Headline
Yum! Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) posted downbeat results for its third quarter
The company reported third-quarter adjusted earnings per share of $1.37 missing the street view of $1.41. Yum! Brands reported a 4% increase in same-store sales for Taco Bell in the U.S., and a 9% unit growth for KFC International. The company's quarterly revenues of $1.826 billion missed the analyst consensus of $1.899 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Bionomics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNOX#NASDAQ">BNOX</a>) shares shot up 170% to $0.5189 after the company announced it secured an AUS$1 million milestone payment from Carina Biotech for its BNC101 oncology program, with the potential to earn up to AUS$118 million.</li>
<li>Shares of Vimeo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) got a boost, surging 44% to $6.91 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter sales guidance above estimates.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) shares were also up, gaining 33% to $2.43 after the company highlighted data showing the potential of inflammasome inhibition to protect pancreatic islet beta cells and attenuate progression from obesity to insulin resistance and type 2 diabetes.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Marqeta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) shares dropped 40% to $3.55 after the company reported worse-than-expected Q3 sales results. Also, multiple firms downgraded their respective ratings on the company and lowered their respective price targets.</li>
<li>Shares of Verrica Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRCA#NASDAQ">VRCA</a>) were down 41% to $0.8499 following downbeat quarterly results.</li>
<li>Bioventus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) was down, falling 18% to $11.19 after the company announced third-quarter results.</li>
</ul>
Commodities In commodity news, oil traded up 0.3% to $71.70 while gold traded up 0.2% at $2,750.20.
Silver traded up 0.4% to $32.725 on Tuesday, while copper rose 0.7% to $4.4645.
Euro zone
European shares closed mostly higher today. The eurozone's STOXX 600 rose 0.06%, Germany's DAX gained 0.57% and France's CAC 40 rose 0.48%. Spain's IBEX 35 Index rose 0.29%, while London's FTSE 100 fell 0.14%.
Spain's consumer confidence indicator declined by 4.6 points to a reading of 84.8 in September.
Asia Pacific Markets
Asian markets closed higher on Tuesday, with Japan's Nikkei 225 gaining 1.11%, Hong Kong's Hang Seng Index gaining 2.14%, China's Shanghai Composite Index gaining 2.32% and India's BSE Sensex gaining 0.88%.
Economics
<ul>
<li>The trade deficit in the U.S. increased to $84.4 billion in September, recording the highest level since April 2022, and above market estimates of a $84.1 billion gap, versus a revised $70.8 billion gap in August.</li>
<li>The ISM services PMI rose to 56 in October, recording the highest reading since Aug. 2022. </li>
<li>The S&amp;P Global composite PMI rose to 54.1 in October compared to 54.0 in September.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41743859/top-3-consumer-stocks-that-may-keep-you-up-at-night-this-quarter">Top 3 Consumer Stocks That May Keep You Up At Night This Quarter</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

BNOX

VMEO

VRCA

ZVSA

Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings

This year&#8217;s <a href="https://www.benzinga.com/markets/esg/24/05/39012013/noaa-meteorologists-predict-aggressive-hurricane-season-what-it-means-for-home-depot-generac-other-s">hurricane season </a>is a deadly one for the eastern and Gulf Coast of the U.S. Several companies and ETFs could be affected by another tropical storm nearing the Gulf Coast.
The Storm: Tropical Storm Rafael, the 17th named storm of the 2024 season, formed in the Caribbean, <a href="https://www.nbcnews.com/weather/hurricanes/tropical-storm-rafael-forms-expected-hurricane-rcna178632">according</a> to NBC.
The storm passed by Jamaica on Tuesday. It is expected to strengthen into a hurricane on Tuesday near the Cayman Islands and pass over Western Cuba. From there, it will likely weaken into a tropical storm before making landfall near New Orleans. The path may change drastically before impacting the U.S.
The heaviest rain of up to 10 inches is expected in Jamaica.
Market Impacts: With a projected path in the Gulf of Mexico, Rafael could disrupt offshore oil and gas production, which could impact companies operating there.
Potentially affected stocks include major energy companies like Exxon Mobil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), and Occidental Petroleum Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>), and ETFs like SPDR S&amp;P Oil &amp; Gas Exploration &amp; Production ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOP#NYSE">XOP</a>) and Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>).
Storms in the Gulf of Mexico can also disrupt refining operations, which could impact refiners such as Marathon Petroleum Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>), Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) and Valero Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>).
Construction companies like Vulcan Materials Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMC#NYSE">VMC</a>) and Martin Marietta Materials Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLM#NYSE">MLM</a>) might benefit from increased demand for repairs and rebuilding.
Recent extreme weather activity is linked to climate change. Hurricanes, which will become even more frequent over time, may encourage homeowners to purchase home generators. Generac Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNRC#NYSE">GNRC</a>) is the largest producer of home generators in the U.S.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41746843/bond-market-fear-gauge-soars-to-1-year-high-ahead-of-us-election-results-bond-vigil">Bond Market Fear Gauge Soars To 1-Year High Ahead Of US Election Results: &#8216;Bond Vigilantes Have Been Voting Early&#8217;</a></li>
</ul>
Photo: Tropical Storm Rafael, 11.5.2024. Courtesy NOAA/Public Domain

Sector ETFs

ETFs

GNRC

Tropical Storm Rafael Could Make US Landfall: 11 Stocks, ETFs To Watch

SPPL

SIMPPLE Australia And Mode Technology To Showcase Advanced Robotic Cleaning Solutions And Software Platform At New Zealand Cleaning Expo On November 6-7

In the current market session, Lennox Intl Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) stock price is at $601.00, after a 0.61% decrease. However, over the past month, the company's stock increased by 2.48%, and in the past year, by 58.07%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1730835070_0.png" alt="Past Year Chart" />

<h3>Lennox Intl P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 26.68 in the Building Products industry, Lennox Intl Inc. has a higher P/E ratio of 28.72. Shareholders might be inclined to think that Lennox Intl Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1730835070_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

P/E Ratio Insights for Lennox Intl

AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) has outperformed the market over the past 15 years by 10.77% on an annualized basis producing an average annual return of 22.43%. Currently, AutoZone has a market capitalization of $51.50 billion. 
Buying $100 In AZO: If an investor had bought $100 of AZO stock 15 years ago, it would be worth $2,140.90 today based on a price of $3046.35 for AZO at the time of writing.
<h3>AutoZone's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730835035_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 15 Years Ago Would Be Worth $2,100 Today

ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) has outperformed the market over the past 10 years by 9.93% on an annualized basis producing an average annual return of 20.84%. Currently, ASML Holding has a market capitalization of $267.40 billion. 
Buying $100 In ASML: If an investor had bought $100 of ASML stock 10 years ago, it would be worth $666.33 today based on a price of $673.07 for ASML at the time of writing.
<h3>ASML Holding's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730835030_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASML

Here's How Much $100 Invested In ASML Holding 10 Years Ago Would Be Worth Today

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Gold Royalty (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) with a Buy and lowers the price target from $5.75 to $5.5.

Price Target

Analyst Ratings

GROY

HC Wainwright & Co. Maintains Buy on Gold Royalty, Lowers Price Target to $5.5

On Monday, Fidelity National Information Services, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) reported <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41709529/fis-reports-strong-third-quarter-2024-results-and-raises-full-year-outlook" rel="noreferrer noopener">third-quarter revenue</a> of $2.57 billion, up 3% year over year, topping the analyst consensus of $2.56 billion. Adjusted&nbsp;EPS of $1.40 beat the analyst consensus of $1.29.
The company expects fiscal 2024 revenue of $10.14 billion &#8211; $10.17 billion (prior $10.12 billion &#8211; $10.17 billion) and adjusted EPS of $5.15 &#8211; $5.20 (prior $5.03 &#8211; $5.11).
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41745824/short-squeeze-globalfoundries-stock-soars-on-q3-earnings-beat-strong-q4-outlook" rel="noreferrer noopener">Short Squeeze &#8211; GlobalFoundries Stock Soars On Q3 Earnings Beat, Strong Q4 Outlook</a>
Multiple analysts rerated the stock after the print. RBC Capital analyst Daniel Perlin maintained Fidelity National Info with an Outperform and raised the <a href="https://www.benzinga.com/quote/FIS/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $95 to $104</a>.
KeyBanc analyst Alex Markgraff remained Sector Weight on Fidelity National Info. Goldman Sachs analyst Will Nance reiterated a Buy on Fidelity National Info with a price target of $100, up from $97.
RBC Capital: Perlin highlighted FIS&#8217; recent performance, noting strength in core banking sales and operating leverage in capital markets. Banking segment adjusted revenue grew by 3% year-over-year to $1.71 billion, with an adjusted EBITDA margin of 45.2%, supported by cost-saving efforts and an increasing proportion of recurring revenue, up 6% year-over-year. The recent acquisition of Dragonfly, which offers liquidity management and fraud prevention for complex commercial clients, enhances FIS&#8217; digital offerings and opens cross-selling opportunities with banks not yet using FIS&#8217; core services.
The Capital Markets segment posted 7% adjusted revenue growth, reaching $730 million, with a 49.9% EBITDA margin. This was attributed to a favorable revenue mix and operational leverage. Management anticipates ongoing margin expansion in the segment, driven by increased recurring revenue and a boost in cross-selling activity across the enterprise, which rose 20% year-to-date.
KeyBanc: Markgraff observed that FIS reported better-than-expected third-quarter results and raised its full-year guidance. However, the increase was primarily due to reduced interest expenses and added Worldpay EMI contributions rather than core operational growth. Adjusted revenue in Banking grew 3% year-over-year, driven by steady recurring revenue. Capital Markets adjusted revenue also rose by 7%, reflecting substantial operating leverage and an advantageous revenue mix.
Despite an upbeat revenue beat, Markgraff noted that higher capital expenditures—partly from vendor pricing pressures—dampened immediate market response to the results. The outlook suggests strong momentum, particularly in Capital Markets, though Banking growth is expected to settle closer to the lower to midpoint of its projected range.
Goldman Sachs: Nance noted that FIS outperformed the S&amp;P with a 67 basis point rise, as investors seemed reassured by consistent performance and reaffirmed medium-term targets. Despite anticipated increases in third-party vendor costs impacting capital expenditures, management expressed confidence in maintaining cash flow in 2025. While Worldpay is no longer central to FIS&#8217; strategy, its EMI continues positively impacting EPS. Operationally, FIS saw strong execution with several key customer wins in the Asia-Pacific region, reinforcing confidence in its execution.
Looking ahead, Nance views FIS as a reliable, defensively positioned investment with moderate revenue growth and steady EPS growth, enhanced by capital returns and efficient margin management. He raised the price target, reflecting peer valuation adjustments driven by FIS&#8217; continued positive performance trajectory.
Price Action: FIS stock is down 3.21% at $86.82 at last check Tuesday.
Image: Shutterstock by PopTika
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41748807/thomson-reuters-q3-earnings-legal-corporate-segments-enjoy-revenue-boost-as-ceo-highlights-ai-inves" target="_blank" rel="noreferrer noopener">Thomson Reuters Q3 Earnings: Legal, Corporate Segments Enjoy Revenue Boost As CEO Highlights AI Investment</a></li>
</ul>

Analyst Color

Reiteration

Fidelity National Information Services' Banking, Capital Markets Growth Drive Optimism, Analysts Say

Needham analyst Serge Belanger reiterates Verrica Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRCA#NASDAQ">VRCA</a>) with a Hold.

Needham Reiterates Hold on Verrica Pharmaceuticals

Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) stock is trading lower on Tuesday. Bank of America expects the stock to experience some volatility after the company&#8217;s striking machinists voted to approve the plane maker&#8217;s <a href="https://www.benzinga.com/markets/equities/24/11/41736062/boeing-workers-end-seven-week-strike-by-accepting-new-contract-with-major-pay-increases">latest labor contract proposal</a>.
What To Know: The International Association of Machinists and Aerospace Workers (IAM) voted to ratify Boeing&#8217;s labor proposal on Monday, with 59% of the votes in favor of the deal.
In a new note to clients on Tuesday, BofA analyst Ronald Epstein said recently appointed Boeing CEO Kelly Ortberg &#8220;added another check to the &#8216;Boeing Turnaround&#8217; list&#8221; by bringing an end to what had been a 53-day strike. Although Epstein is optimistic about the news, he cautioned that a return to normal operations could still take a while. 
&#8220;While the strike ending and workers returning to the shopfloor is a meaningful step in the right direction, ramping back up will take time,&#8221; the BofA analyst said. 
Epstein pumped the brakes on Boeing&#8217;s production ramp, noting that some employees will have to go through retraining sessions after returning to work by Nov. 12.
The offer included a 38% wage increase over four years, enhanced retirement contributions and improved health benefits. Union members also gained flexibility in receiving their one-time $12,000 ratification bonus, with options to allocate it toward their paycheck, 401(k) or a combination of the two.
&#8220;While the full impact of the strike and how quickly production restarts remain to be determined we leave our estimates unchanged and maintain our Neutral rating. However, we do expect to see some volatility in Boeing&#8217;s share price,&#8221; the analyst said.
Related Link: <a href="https://www.benzinga.com/trading-ideas/technicals/24/11/41712908/palantir-q3-earnings-on-deck-as-cathie-wood-cuts-stake">Palantir Q3 Earnings On Deck As Cathie Wood Cuts Stake</a>
BA Price Action: At the time of writing, Boeing shares were down 2.05% at $151.94, per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Photo via Shutterstock

Movers

Boeing Stock Is Trading Lower, Analyst Sees Volatility Ahead: What's Going On?

Wedbush analyst Nick Setyan reiterates Wingstop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) with a Outperform and maintains $390 price target.

WING

Wedbush Reiterates Outperform on Wingstop, Maintains $390 Price Target

alab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) reported better-than-expected third-quarter <a href="https://www.benzinga.com/quote/ALAB/earnings">EPS and sales on Monday</a>.
Astera Labs reported quarterly earnings of 23 cents per share which beat the analyst consensus estimate of 17 cents per share. The company reported quarterly sales of $113.09 million which beat the analyst consensus estimate of $97.44 million.
&#8220;Astera Labs delivered strong Q3 results, setting our fifth consecutive quarterly revenue record and grew 47% versus the previous quarter,&#8221; said Jitendra Mohan, Astera Labs&#8217; Chief Executive Officer. &#8220;Our business has now entered a new growth phase with multiple product families ramping across AI platforms based upon both third-party GPUs and internally developed AI accelerators. With expanding product portfolio including the new Scorpio Fabric Switches, we are cementing our position as a critical part of AI connectivity infrastructure, delivering increased value to our hyperscaler customers, and unlocking additional multi-year growth trajectories for Astera.&#8221;
Astera Labs said it sees fourth-quarter revenue of $126 million to $130 million and adjusted earnings of 25 cents to 26 cents per share.
Astera Labs shares jumped 38.7% to trade at $96.60 on Tuesday.
These analysts made changes to their price targets on Astera Labs following earnings announcement.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/60a3a5a849aa07000157ebd9/tom-o'malley">Barclays analyst Tom O&#8217;Malley</a> maintained Astera Labs with an Overweight and raised the price target from $70 to $87.</li>
<li>Craig-Hallum analyst Richard Shannon maintained the stock with a Buy and raised the price target from $75 to $105.</li>
<li>Deutsche Bank analyst Ross Seymore maintained Astera Labs with a Buy and boosted the price target from $60 to $100.</li>
<li>J<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59f1c1bdefacff0001706787/harlan-sur">P Morgan analyst Harlan Sur</a> maintained the stock with an Overweight and raised the price target from $70 to $110.</li>
<li>Stifel analyst Tore Svanberg maintained Astera Labs with a Buy and boosted the price target from $80 to $100.</li>
<li>Morgan Stanley analyst Joseph Moore maintained Astera Labs with an Overweight and raised the price target from $74 to $94.</li>
<li>Roth MKM analyst Suji Desilva maintained the stock with a Buy and raised the price target from $80 to $105.</li>
</ul>
Considering buying ALAB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="573" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05134431/image-35-1024x573.png" alt="" class="wp-image-631048" style="width:692px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05134431/image-35-1024x573.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05134431/image-35-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05134431/image-35-768x430.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05134431/image-35.png 1192w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41746021/this-ebay-analyst-turns-bullish-here-are-top-5-upgrades-for-tuesday">This eBay Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday</a></li>
</ul>

ALAB

These Analysts Boost Their Forecasts On Astera Labs After Upbeat Results

Kirby's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEX#NYSE">KEX</a>) short percent of float has risen 14.47% since its last report. The company recently reported that it has 928 thousand shares sold short, which is 1.82% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Kirby Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730834122_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Kirby has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Kirby's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Kirby's peer group average for short interest as a percentage of float is 3.14%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Kirby?

ZIM Integrated Shipping's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) short percent of float has risen 12.27% since its last report. The company recently reported that it has 17.67 million shares sold short, which is 18.76% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.48 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>ZIM Integrated Shipping Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730834117_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for ZIM Integrated Shipping has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing ZIM Integrated Shipping's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, ZIM Integrated Shipping's peer group average for short interest as a percentage of float is 2.44%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About ZIM Integrated Shipping?

Bright Horizons Family's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFAM#NYSE">BFAM</a>) short percent of float has risen 21.52% since its last report. The company recently reported that it has 492 thousand shares sold short, which is 0.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.37 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Bright Horizons Family Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730834111_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Bright Horizons Family has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Bright Horizons Family's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Bright Horizons Family's peer group average for short interest as a percentage of float is 5.72%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

BFAM

Peering Into Bright Horizons Family's Recent Short Interest

Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) shares are trading lower on Tuesday following weak third-quarter <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41730393/cleveland-cliffs-q3-earnings-revenue-eps-miss-on-weaker-demand-and-pricing-shares-slide" rel="noreferrer noopener">results reported on Tuesday</a>.
The company reported third-quarter revenue of&nbsp;$4.57 billion, versus&nbsp;estimates&nbsp;of $4.77 billion, and adjusted loss per share of $0.33, versus estimates for a loss of $0.27.
Cleveland-Cliffs lowered its capital expenditures outlook for full year 2024 from a range of $650 million to $700 million to a new range of<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> $600 million to $650 million</a>.
In the earnings press release, the company said Stelco&#8217;s assets are well-capitalized, and it expects to benefit from the company&#8217;s cost advantages and strong business model on day one. Cleveland-Cliffs noted Stelco&#8217;s business has &#8220;virtually no exposure&#8221; to the automotive sector.&nbsp;
B Riley Securities analyst Lucas N. Pipes says that based on management&#8217;s earlier comments, they previously projected $985 million for 2025 and anticipate insights on the significant reductions.
The analyst adds that Cliffs&#8217; acquisition of Stelco was finalized on November 1, and they are eager to hear management&#8217;s thoughts on the integration process, potential synergies, debt reduction, and product mix.
Also, the analyst anticipates updated insights from management regarding the timeline for the integration process of the Stelco acquisition and the complete realization of the <a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/39770873/cleveland-cliffs-doubles-down-on-steel-with-2-5b-acquisition-expects-120m-in-annual-savings" rel="noreferrer noopener">$120 million in cost synergies</a>.
The analyst maintains the <a href="https://www.benzinga.com/quote/CLF/analyst-ratings">Buy rating and $21 price forecast.</a>
KeyBanc Capital Markets analyst Philip Gibbs writes that Cleveland-Cliffs reported EBITDA of $124 million for the quarter, compared to their estimate of $134 million. The slight shortfall in steel volumes appears to be linked to adjustments in automotive production and inventory.
Investors can gain exposure to the stock via&nbsp;SPDR S&amp;P Metals &amp; Mining ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XME#NYSE">XME</a>) and&nbsp;VanEck Steel ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLX#NYSE">SLX</a>).
Price Action: CLF shares are down 10.3% at $11.76 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/esg/24/11/41722922/trump-vs-harris-evgo-cleveland-cliffs-plug-power-nucor-brace-for-2024-election-impact" target="_blank" rel="noreferrer noopener">Trump Vs. Harris: EVgo, Cleveland-Cliffs, Plug Power, Nucor Brace For 2024 Election Impact</a></li>
</ul>

Cleveland-Cliffs' Q3 Shortfall Linked To Automotive Adjustments; Analysts Await Stelco Integration Insights

TD Cowen lowered the firm's price target on Verrica Pharmaceuticals (VRCA) to $10 from $15 and keeps a Buy rating on the shares. The firm said due ...

Verrica Pharmaceuticals price target lowered to $10 from $15 at TD Cowen

Verrica Pharmaceuticals (VRCA) announced the acceptance of two abstracts that will be presented as posters at the Fall Clinical Dermatology Confere...

Verrica to preset results on VP-315 at Fall Clinical Dermatology Conference

Verrica Pharmaceuticals ( ($VRCA) ) has issued an update. Verrica Pharmaceuticals is undergoing significant leadership changes and financial restru...

Verrica Pharmaceuticals Undergoes Leadership and Financial Restructuring

Reports Q3: Verrica recognized negative net product revenue of $1.9M in the third quarter of 2024 which relates to an increase in our return reserv...

Verrica Pharmaceuticals reports Q3 EPS (43c), consensus (37c)

Verrica Pharmaceuticals Non-GAAP EPS of -$0.43 misses by $0.04

Verrica Pharmaceuticals ( ($VRCA) ) has released its Q3 earnings. Here is a breakdown of the information Verrica Pharmaceuticals presented to its i...

Verrica Pharmaceuticals: Financial Struggles Amid Strategic Shifts

RBC Capital downgraded Verrica Pharmaceuticals (VRCA) to Sector Perform from Outperform with a price target of $2, down from $11. Published first o...

Verrica downgraded to Sector Perform from Outperform at RBC Capital

RBC Capital analyst Gregory Renza downgraded Verrica Pharmaceuticals (VRCA) to Sector Perform from Outperform with a price target of $2, down from ...

RBC downgrades Verrica Pharmaceuticals on 'uncertain path' forward

Needham analyst Serge Belanger has maintained their neutral stance on VRCA stock, giving a Hold rating today. Serge Belanger has given his Hold rat...

Hold Rating on Verrica Pharmaceuticals Amidst Restructuring and Financial Uncertainty

Stacy Ku, an analyst from TD Cowen, maintained the Buy rating on Verrica Pharmaceuticals (VRCA – Research Report). The associated price target was ...

Strategic Management and Demand Prospects Justify Buy Rating Amid Inventory Challenges

Press Releases

Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York

Legal

SHAREHOLDER ALERT: Morris Kandinov Investigating SHLS, VRCA, IRTC and NSSC; Shareholders are Encouraged to Contact the Firm

VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA

VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA

Health Care

General

Verrica Pharmaceuticals Announces Restructuring of Commercial Organization

Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference

Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements

Comments

Verrica Pharmaceuticals

Verrica Pharmaceuticals (VRCA) オプション

Verrica Pharmaceuticals (NASDAQ:VRCA) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル